Exact Mass: 491.209
Exact Mass Matches: 491.209
Found 425 metabolites which its exact mass value is equals to given mass value 491.209
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Barnidipine
Grapiprant
C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent C177182 - Prostaglandin Receptor Antagonist C274 - Antineoplastic Agent
5-O-[(3S)-1-Benzylpyrrolidin-3-yl] 3-O-methyl (4R)-2,6-dimethyl-4-(3-nitrophenyl)-3,4-dihydropyridine-3,5-dicarboxylate
Ala Asp Met Arg
Ala Asp Arg Met
Ala Asp Thr Trp
Ala Asp Trp Thr
Ala Glu Ser Trp
Ala Glu Trp Ser
Ala Met Asp Arg
Ala Met Arg Asp
Ala Arg Asp Met
Ala Arg Met Asp
Ala Ser Glu Trp
Ala Ser Trp Glu
Ala Thr Asp Trp
Ala Thr Trp Asp
Ala Trp Asp Thr
Ala Trp Glu Ser
Ala Trp Ser Glu
Ala Trp Thr Asp
Cys Asp Arg Val
Cys Asp Val Arg
Cys Glu Ile Gln
Cys Glu Leu Gln
Cys Glu Gln Ile
Cys Glu Gln Leu
Cys Ile Glu Gln
Cys Ile Gln Glu
Cys Lys Asn Gln
Cys Lys Gln Asn
Cys Leu Glu Gln
Cys Leu Gln Glu
Cys Asn Lys Gln
Cys Asn Gln Lys
Cys Gln Glu Ile
Cys Gln Glu Leu
Cys Gln Ile Glu
Cys Gln Lys Asn
Cys Gln Leu Glu
Cys Gln Asn Lys
Cys Arg Asp Val
Cys Arg Val Asp
Cys Val Asp Arg
Cys Val Arg Asp
Asp Ala Met Arg
Asp Ala Arg Met
Asp Ala Thr Trp
Asp Ala Trp Thr
Asp Cys Arg Val
Asp Cys Val Arg
Asp Phe Asn Pro
Asp Phe Pro Asn
Asp Ile Met Asn
Asp Ile Asn Met
Asp Leu Met Asn
Asp Leu Asn Met
Asp Met Ala Arg
Asp Met Ile Asn
Asp Met Leu Asn
Asp Met Asn Ile
Asp Met Asn Leu
Asp Met Gln Val
Asp Met Arg Ala
Asp Met Val Gln
Asp Asn Phe Pro
Asp Asn Ile Met
Asp Asn Leu Met
Asp Asn Met Ile
Asp Asn Met Leu
Asp Asn Pro Phe
Asp Pro Phe Asn
Asp Pro Asn Phe
Asp Gln Met Val
Asp Gln Val Met
Asp Arg Ala Met
Asp Arg Cys Val
Asp Arg Met Ala
Asp Arg Val Cys
Asp Thr Ala Trp
Asp Thr Trp Ala
Asp Val Cys Arg
Asp Val Met Gln
Asp Val Gln Met
Asp Val Arg Cys
Asp Trp Ala Thr
Asp Trp Thr Ala
Glu Ala Ser Trp
Glu Ala Trp Ser
Glu Cys Ile Gln
Glu Cys Leu Gln
Glu Cys Gln Ile
Glu Cys Gln Leu
Glu Gly Met Arg
Glu Gly Arg Met
Glu Gly Thr Trp
Glu Gly Trp Thr
Glu Ile Cys Gln
Glu Ile Gln Cys
Glu Leu Cys Gln
Glu Leu Gln Cys
Glu Met Gly Arg
Glu Met Asn Val
Glu Met Arg Gly
Glu Met Val Asn
Glu Asn Met Val
Glu Asn Val Met
Glu Gln Cys Ile
Glu Gln Cys Leu
Glu Gln Ile Cys
Glu Gln Leu Cys
Glu Arg Gly Met
Glu Arg Met Gly
Glu Ser Ala Trp
Glu Ser Trp Ala
Glu Thr Gly Trp
Glu Thr Trp Gly
Glu Val Met Asn
Glu Val Asn Met
Glu Trp Ala Ser
Glu Trp Gly Thr
Glu Trp Ser Ala
Glu Trp Thr Gly
Phe Asp Asn Pro
Phe Asp Pro Asn
Phe Asn Asp Pro
Phe Asn Pro Asp
Phe Pro Asp Asn
Phe Pro Asn Asp
Gly Glu Met Arg
Gly Glu Arg Met
Gly Glu Thr Trp
Gly Glu Trp Thr
Gly Met Glu Arg
Gly Met Arg Glu
Gly Arg Glu Met
Gly Arg Met Glu
Gly Thr Glu Trp
Gly Thr Trp Glu
Gly Trp Glu Thr
Gly Trp Thr Glu
Ile Cys Glu Gln
Ile Cys Gln Glu
Ile Asp Met Asn
Ile Asp Asn Met
Ile Glu Cys Gln
Ile Glu Gln Cys
Ile Met Asp Asn
Ile Met Asn Asp
Ile Asn Asp Met
Ile Asn Met Asp
Ile Gln Cys Glu
Ile Gln Glu Cys
Lys Cys Asn Gln
Lys Cys Gln Asn
Lys Asn Cys Gln
Lys Asn Gln Cys
Lys Gln Cys Asn
Lys Gln Asn Cys
Leu Cys Glu Gln
Leu Cys Gln Glu
Leu Asp Met Asn
Leu Asp Asn Met
Leu Glu Cys Gln
Leu Glu Gln Cys
Leu Met Asp Asn
Leu Met Asn Asp
Leu Asn Asp Met
Leu Asn Met Asp
Leu Gln Cys Glu
Leu Gln Glu Cys
Met Ala Asp Arg
Met Ala Arg Asp
Met Asp Ala Arg
Met Asp Ile Asn
Met Asp Leu Asn
Met Asp Asn Ile
Met Asp Asn Leu
Met Asp Gln Val
Met Asp Arg Ala
Met Asp Val Gln
Met Glu Gly Arg
Met Glu Asn Val
Met Glu Arg Gly
Met Glu Val Asn
Met Gly Glu Arg
Met Gly Arg Glu
Met Ile Asp Asn
Met Ile Asn Asp
Met Leu Asp Asn
Met Leu Asn Asp
Met Asn Asp Ile
Met Asn Asp Leu
Met Asn Glu Val
Met Asn Ile Asp
Met Asn Leu Asp
Met Asn Val Glu
Met Gln Asp Val
Met Gln Val Asp
Met Arg Ala Asp
Met Arg Asp Ala
Met Arg Glu Gly
Met Arg Gly Glu
Met Val Asp Gln
Met Val Glu Asn
Met Val Asn Glu
Met Val Gln Asp
Asn Cys Lys Gln
Asn Cys Gln Lys
Asn Asp Phe Pro
Asn Asp Ile Met
Asn Asp Leu Met
Asn Asp Met Ile
Asn Asp Met Leu
Asn Asp Pro Phe
Asn Glu Met Val
Asn Glu Val Met
Asn Phe Asp Pro
Asn Phe Pro Asp
Asn Ile Asp Met
Asn Ile Met Asp
Asn Lys Cys Gln
Asn Lys Gln Cys
Asn Leu Asp Met
Asn Leu Met Asp
Asn Met Asp Ile
Asn Met Asp Leu
Asn Met Glu Val
Asn Met Ile Asp
Asn Met Leu Asp
Asn Met Val Glu
Asn Pro Asp Phe
Asn Pro Phe Asp
Asn Gln Cys Lys
Asn Gln Lys Cys
Asn Val Glu Met
Asn Val Met Glu
Pro Asp Phe Asn
Pro Asp Asn Phe
Pro Phe Asp Asn
Pro Phe Asn Asp
Pro Asn Asp Phe
Pro Asn Phe Asp
Gln Cys Glu Ile
Gln Cys Glu Leu
Gln Cys Ile Glu
Gln Cys Lys Asn
Gln Cys Leu Glu
Gln Cys Asn Lys
Gln Asp Met Val
Gln Asp Val Met
Gln Glu Cys Ile
Gln Glu Cys Leu
Gln Glu Ile Cys
Gln Glu Leu Cys
Gln Ile Cys Glu
Gln Ile Glu Cys
Gln Lys Cys Asn
Gln Lys Asn Cys
Gln Leu Cys Glu
Gln Leu Glu Cys
Gln Met Asp Val
Gln Met Val Asp
Gln Asn Cys Lys
Gln Asn Lys Cys
Gln Val Asp Met
Gln Val Met Asp
Arg Ala Asp Met
Arg Ala Met Asp
Arg Cys Asp Val
Arg Cys Val Asp
Arg Asp Ala Met
Arg Asp Cys Val
Arg Asp Met Ala
Arg Asp Val Cys
Arg Glu Gly Met
Arg Glu Met Gly
Arg Gly Glu Met
Arg Gly Met Glu
Arg Met Ala Asp
Arg Met Asp Ala
Arg Met Glu Gly
Arg Met Gly Glu
Arg Val Cys Asp
Arg Val Asp Cys
Ser Ala Glu Trp
Ser Ala Trp Glu
Ser Glu Ala Trp
Ser Glu Trp Ala
Ser Trp Ala Glu
Ser Trp Glu Ala
Thr Ala Asp Trp
Thr Ala Trp Asp
Thr Asp Ala Trp
Thr Asp Trp Ala
Thr Glu Gly Trp
Thr Glu Trp Gly
Thr Gly Glu Trp
Thr Gly Trp Glu
Thr Trp Ala Asp
Thr Trp Asp Ala
Thr Trp Glu Gly
Thr Trp Gly Glu
Val Cys Asp Arg
Val Cys Arg Asp
Val Asp Cys Arg
Val Asp Met Gln
Val Asp Gln Met
Val Asp Arg Cys
Val Glu Met Asn
Val Glu Asn Met
Val Met Asp Gln
Val Met Glu Asn
Val Met Asn Glu
Val Met Gln Asp
Val Asn Glu Met
Val Asn Met Glu
Val Gln Asp Met
Val Gln Met Asp
Val Arg Cys Asp
Val Arg Asp Cys
Trp Ala Asp Thr
Trp Ala Glu Ser
Trp Ala Ser Glu
Trp Ala Thr Asp
Trp Asp Ala Thr
Trp Asp Thr Ala
Trp Glu Ala Ser
Trp Glu Gly Thr
Trp Glu Ser Ala
Trp Glu Thr Gly
Trp Gly Glu Thr
Trp Gly Thr Glu
Trp Ser Ala Glu
Trp Ser Glu Ala
Trp Thr Ala Asp
Trp Thr Asp Ala
Trp Thr Glu Gly
Trp Thr Gly Glu
4-METHOXYPHENYL 2-AZIDO-3,6-DI-O-BENZYL-2-DEOXY-BETA-D-GLUCOPYRANOSIDE
Barnidipine
C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Grapiprant
C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent C177182 - Prostaglandin Receptor Antagonist C274 - Antineoplastic Agent
2-(4-Biphenylyloxy)-4-[1-(piperidine-4-yl)-4-(4-fluorophenyl)-5-imidazolyl]pyrimidine
3-(3,4-dimethoxyphenyl)-6,7-dimethoxy-2-methyl-N-(6-methyl-2-pyridinyl)-1-oxo-3,4-dihydroisoquinoline-4-carboxamide
3,4,5-triethoxy-N-[4-(4-methylsulfonyl-1-piperazinyl)phenyl]benzamide
2-[[2-(1-benzotriazolyl)-1-oxoethyl]-propan-2-ylamino]-2-(2,5-dimethoxyphenyl)-N-(2-furanylmethyl)acetamide
3-methoxy-N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
(3R)-3-(2-hydroxyethyl)-2-N-propan-2-yl-4-[3-[(E)-prop-1-enyl]phenyl]-6-N-(1,3-thiazol-2-yl)-1,3-dihydropyrrolo[3,4-c]pyridine-2,6-dicarboxamide
1-[(1R)-1-[1,3-benzodioxol-5-yl(oxo)methyl]-1-(hydroxymethyl)-7-methoxy-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]ethanone
1-[2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[(4-phenoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-3-propan-2-ylurea
2-methoxy-N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
2-methoxy-N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
1-[2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(4-phenoxyphenyl)sulfonylamino]oxan-2-yl]ethyl]-3-propan-2-ylurea
2-methoxy-N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
2-methoxy-N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
1-[2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[(4-phenoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-3-propan-2-ylurea
N-[(2R,3R)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-methoxybenzenesulfonamide
N-[(2R,3S)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-methoxybenzenesulfonamide
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-methoxybenzenesulfonamide
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-methoxybenzenesulfonamide
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-methoxybenzenesulfonamide
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-methoxybenzenesulfonamide
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-methoxybenzenesulfonamide
2-methoxy-N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
4-methoxy-N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
4-methoxy-N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
4-methoxy-N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
3-methoxy-N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
3-methoxy-N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
1-[2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[(4-phenoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-3-propan-2-ylurea
1-[2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[(4-phenoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-3-propan-2-ylurea
1-[2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[(4-phenoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-3-propan-2-ylurea
[(1S)-1-(hydroxymethyl)-7-methoxy-1-methylsulfonyl-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]-(4-oxanyl)methanone
N-[(2S,3S)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-methoxybenzenesulfonamide
N-[(2R,3R)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-methoxybenzenesulfonamide
N-[(2R,3S)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-methoxybenzenesulfonamide
N-[(2S,3S)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-methoxybenzenesulfonamide
N-[(2S,3R)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-methoxybenzenesulfonamide
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-methoxybenzenesulfonamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-methoxybenzenesulfonamide
2-methoxy-N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
2-methoxy-N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
4-methoxy-N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
4-methoxy-N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
4-methoxy-N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
4-methoxy-N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
3-methoxy-N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
3-methoxy-N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
3-methoxy-N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
3-methoxy-N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
1-[2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[(4-phenoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-3-propan-2-ylurea
1-[2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[(4-phenoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-3-propan-2-ylurea
1-[(1S)-1-[1,3-benzodioxol-5-yl(oxo)methyl]-1-(hydroxymethyl)-7-methoxy-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]ethanone
[(1R)-1-(hydroxymethyl)-7-methoxy-1-methylsulfonyl-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]-(4-oxanyl)methanone
8,9-dehydro-10-epi-ryanodine
{"Ingredient_id": "HBIN013583","Ingredient_name": "8,9-dehydro-10-epi-ryanodine","Alias": "NA","Ingredient_formula": "C25H33NO9","Ingredient_Smile": "CC(C)C1(C(C2(C3(CC4(C1(C2(C5(C3(CCC(=C)C5O)O)O4)O)C)O)C)O)OC(=O)C6=CC=CN6)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4910","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}